MERCK & CO., INC. (MRK)
Clinical trial NCT04665037 updates: 1. completion date: 2026-12-31 → 2027-04-15 2. primary completion date: 2026-12-16 → 2027-03-31
Clinical trial NCT04665037 updates: 1. completion date: 2026-12-31 → 2027-04-15 2. primary completion date: 2026-12-16 → 2027-03-31
📉 **NEGATIVE** • Medium confidence analysis (69%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (20%) **Content type:** Clinical